C170H192Cl3F13N38O25 — CID 158953557
methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-2,5-dimethyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-4-(1H-imidazole-5-carbonyl)-2,5-dimethylpiperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R)-2-methyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-fluoro-4-[[6-[(2R)-2-methyl-4-[(2S)-2-methyl-1-(methylcarbamoyl)pyrrolidine-2-carbonyl]piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 158953557) has the molecular formula C170H192Cl3F13N38O25 and a molecular weight of 3520.98 g/mol. Its IUPAC name is methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-2,5-dimethyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-4-(1H-imidazole-5-carbonyl)-2,5-dimethylpiperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R)-2-methyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-fluoro-4-[[6-[(2R)-2-methyl-4-[(2S)-2-methyl-1-(methylcarbamoyl)pyrrolidine-2-carbonyl]piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
| Compound Name | methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-2,5-dimethyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-4-(1H-imidazole-5-carbonyl)-2,5-dimethylpiperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R)-2-methyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-fluoro-4-[[6-[(2R)-2-methyl-4-[(2S)-2-methyl-1-(methylcarbamoyl)pyrrolidine-2-carbonyl]piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 158953557 |
| Molecular Formula | C170H192Cl3F13N38O25 |
| Molecular Weight | 3520.98 g/mol |
| Exact Mass | 3517.38 |
| IUPAC Name | methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-2,5-dimethyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R,5S)-4-(1H-imidazole-5-carbonyl)-2,5-dimethylpiperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-chloro-4-[[6-[(2R)-2-methyl-4-(methylcarbamoyl)piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;methyl N-[(2S)-1-[(2S)-2-[5-[4-[5-fluoro-4-[[6-[(2R)-2-methyl-4-[(2S)-2-methyl-1-(methylcarbamoyl)pyrrolidine-2-carbonyl]piperazin-1-yl]pyridine-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | CNC(=O)N1CCC[C@@]1(C)C(=O)N1CCN(c2ccc(C(=O)Nc3cc(OC(F)(F)F)c(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)cc3F)cn2)[C@H](C)C1.CNC(=O)N1CCN(c2ccc(C(=O)Nc3cc(OC(F)(F)F)c(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)cc3Cl)cn2)[C@H](C)C1.CNC(=O)N1C[C@@H](C)N(c2ccc(C(=O)Nc3cc(OC(F)(F)F)c(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)cc3Cl)cn2)C[C@@H]1C.COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3cc(Cl)c(NC(=O)c4ccc(N5C[C@H](C)N(C(=O)c6cnc[nH]6)C[C@H]5C)nc4)cc3OC(F)(F)F)cc2)[nH]1)C(C)C |
| InChI | InChI=1S/C46H54F4N10O7.C43H46ClF3N10O6.C41H47ClF3N9O6.C40H45ClF3N9O6/c1-26(2)38(56-44(65)66-6)41(62)59-17-7-9-35(59)39-53-24-34(54-39)29-12-10-28(11-13-29)31-21-32(47)33(22-36(31)67-46(48,49)50)55-40(61)30-14-15-37(52-23-30)58-20-19-57(25-27(58)3)42(63)45(4)16-8-18-60(45)43(64)51-5;1-23(2)37(54-42(61)62-5)41(60)55-14-6-7-34(55)38-50-19-32(52-38)27-10-8-26(9-11-27)29-15-30(44)31(16-35(29)63-43(45,46)47)53-39(58)28-12-13-36(49-17-28)56-20-25(4)57(21-24(56)3)40(59)33-18-48-22-51-33;1-22(2)35(51-40(58)59-6)38(56)52-15-7-8-32(52)36-48-19-31(49-36)26-11-9-25(10-12-26)28-16-29(42)30(17-33(28)60-41(43,44)45)50-37(55)27-13-14-34(47-18-27)53-20-24(4)54(21-23(53)3)39(57)46-5;1-22(2)34(50-39(57)58-5)37(55)53-14-6-7-31(53)35-47-20-30(48-35)25-10-8-24(9-11-25)27-17-28(41)29(18-32(27)59-40(42,43)44)49-36(54)26-12-13-33(46-19-26)52-16-15-51(21-23(52)3)38(56)45-4/h10-15,21-24,26-27,35,38H,7-9,16-20,25H2,1-6H3,(H,51,64)(H,53,54)(H,55,61)(H,56,65);8-13,15-19,22-25,34,37H,6-7,14,20-21H2,1-5H3,(H,48,51)(H,50,52)(H,53,58)(H,54,61);9-14,16-19,22-24,32,35H,7-8,15,20-21H2,1-6H3,(H,46,57)(H,48,49)(H,50,55)(H,51,58);8-13,17-20,22-23,31,34H,6-7,14-16,21H2,1-5H3,(H,45,56)(H,47,48)(H,49,54)(H,50,57)/t27-,35+,38+,45+;24-,25+,34+,37+;23-,24+,32+,35+;23-,31+,34+/m1111/s1 |
| InChIKey | JLSNNLZSJPQDQW-OSRRUFNCSA-N |
| XLogP | 28.22 |
| TPSA | 733.44 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 249 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3520.98 |
| LogP ≤ 5 | 28.22 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 38 |